The Pharmaceutical Journal
Vol 279 No 7481 p663
8 December 2007

Disciplinary Committee

The Disciplinary Committee met at the Royal Pharmaceutical Society of Great Britain on Tuesday 4 and Wednesday 5 December 2007 to hear the following Statutory Committee inquiry:

1. The new inquiry into a complaint by the Council of the Society against Robert Lyndsey Sherman (registration number 78127) which alleges that the submission to the Prescription Pricing Authority for payment prescriptions endorsed to the effect that all the items called for had been dispensed when this was not true, resulting in payments of £6467.15 and £2996.81 to which he was not entitled; the supply of Quetiapine 100mg tablets at a dosage of one per day against prescriptions calling for 2 per day, and endorsing the prescriptions to the effect that all the items called for had been dispensed; the supply of Folic Acid 5mg tablets at a dosage of one per day against prescriptions calling for 2 per day, and endorsing the prescriptions to the effect that all the items called for had been dispensed; the supply of Sinemet-Plus 125mg tablets at a dosage of one tablet to be taken twice a day against prescriptions calling for one tablet three times per day, and endorsing the prescriptions to the effect that all the items called for had been dispensed; certifying on the reverse of two NHS prescriptions that a patient was over 60 years of age and accordingly exempt from payment of NHS prescription fees when in fact that patient was 57 and had paid the required fee; a failure to promptly transfer patient-returned medicines to disposal containers; the storage of patient-returned medicines in the garage of his home and in his car, may amount to misconduct.

The Disciplinary Committee will meet at the Royal Pharmaceutical Society of Great Britain on Monday 10, Tuesday 11, Wednesday 12 and Thursday 13 December 2007 at 9.30am to hear the following Statutory Committee inquiries:

1. The new inquiry into a complaint by the Council of the Society against Khalid Hag-Ali (registration number F785) which alleges that: allowing an individual who was not fully registered with the General Medical Council to work as a doctor at the medical centre Mr Hag-Ali owned; failing to take adequate steps to check the individual’s status with the GMC and/or to check that, if registered with the GMC, such registration permitted him to lawfully perform the work that he was engaged to perform as a doctor at the medical centre; when it was brought to the attention of Mr Hag-Ali that the individual was not fully registered with the GMC, telling that person that it was none of his business, or words to that effect, and allowing the individual to continue working at the medical centre as a doctor; and, allowing the individual to issue numerous prescriptions when he was not authorised to do so, may amount to misconduct.

2. The new inquiry into a complaint by the Council of the Society against Alexander Stanislaw Bachanek (registration number 68515) which alleges that: the supply of four boxes of Omnic (Tamsulosin Hydrochloride) MR 400mcg capsules for a patient in response to a prescription calling for 112 x Tamoxifen tablets 20mg; the sale of 60 x Solpadeine Plus tablets and 160mls of Night Nurse by an employee when a pharmacist was not present in the pharmacy to supervise the sale; and causing or permitting unqualified members of staff to supply, in circumstances corresponding to retail sales to approximately four patients, medicinal products which were not on a general sale list, may amount to misconduct.

Fitness to Practise Committee Secretariat